Your browser doesn't support javascript.
loading
Implications for IV posaconazole dosing in the era of obesity.
Wasmann, Roeland E; Smit, Cornelis; van Donselaar, Marieke H; van Dongen, Eric P A; Wiezer, René M J; Verweij, Paul E; Burger, David M; Knibbe, Catherijne A J; Brüggemann, Roger J M.
Afiliação
  • Wasmann RE; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Smit C; Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands.
  • van Donselaar MH; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands.
  • van Dongen EPA; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Wiezer RMJ; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Verweij PE; Department of Anaesthesiology, Intensive Care and Pain Management, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Burger DM; Department of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Knibbe CAJ; Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands.
  • Brüggemann RJM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
J Antimicrob Chemother ; 75(4): 1006-1013, 2020 04 01.
Article em En | MEDLINE | ID: mdl-31971567
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida Idioma: En Ano de publicação: 2020 Tipo de documento: Article